Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03616171 · ClinicalTrials.gov registry record · NA
A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 Diabetes
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03616171: Completed NA study, sponsored by Emory University.
NCT03616171 is a NA study that has completed, run by Emory University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03616171, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study is a prospective unblinded randomized trial to evaluate the feasibility of conducting a sleep extension intervention trial and the sleep extension intervention among the young adults. The study also wants to assess whether a sleep-extension intervention has an impact on the insulin resistance levels of young adults. The intervention consists of an education session and to extend the sleep time at least one hour but can be up to 2 hours per night for 4 weeks.
Primary Outcome
Feasibility of the study is assessed by number of enrollments in the study over a one year period. Study proposes to enroll minimum 20 subjects to meet the feasibility of the study.
Interventions
- OTHER Control
- BEHAVIORAL SLEEP-Extend intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-08-30 |
| Est. Completion | 2018-04-02 |
| Phase | NA |
What the finished NCT03616171 record still lists
NCT03616171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03616171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03616171 about?
NCT03616171 is a clinical study titled "A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 Diabetes". The study is a prospective unblinded randomized trial to evaluate the feasibility of conducting a sleep extension intervention trial and the sleep extension intervention among the young adults. The study also wants to assess whether a sleep-extension intervention has an impact on the insulin resista...
What is the current status of trial NCT03616171?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-08-30. Estimated completion is 2018-04-02.
What interventions are being tested in trial NCT03616171?
The interventions under investigation include: Control (OTHER), SLEEP-Extend intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03616171?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03616171's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI